查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1608147

術中神經監測市場：按類型、方式和應用分類 - 全球預測 2025-2030

Intraoperative Neuromonitoring Market by Type (Insource IONM, Outsource IONM), Modality (Brainstem Auditory Evoked Potentials, Electroencephalography, Electromyography), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

術中神經監測市場2023年估值為31.3億美元，預計到2024年將達到33.1億美元，複合年成長率為5.69%，到2030年達到46.2億美元。

術中神經監測 (IONM) 是手術期間使用的一種專門程序，用於即時監測神經通路並降低神經或脊髓損傷的風險。對 IONM 的需求源於其能夠向外科醫生提供即時回饋並提高患者安全性，特別是在涉及大腦、脊椎和神經的複雜手術期間。 IONM具有廣泛的應用範圍，包括整形外科、神經外科、血管外科和耳鼻喉科。最終用途包括醫院、手術中心和專科診所，手術量的增加和盡量減少手術併發症的願望推動了需求。

主要市場統計
基準年[2023] 31.3億美元
預計年份 [2024] 33.1億美元
預測年份 [2030] 46.2億美元
複合年成長率（%） 5.69%

市場洞察揭示了影響成長的幾個關鍵因素，包括技術進步、需要更多手術的人口老化以及醫療保健專業人員對患者安全意識的提高。隨著醫療基礎設施的不斷擴大以及人工智慧和機器學習的整合，新興市場的機會比比皆是，以提高監測準確性和預測分析。為了抓住這些機會，企業應專注於擴大在這些地區的業務，並投資於更複雜、更易於使用的設備的研發。

阻礙市場成長的挑戰包括設備成本高、缺乏熟練的專業人員來操作 IONM 技術以及複雜的監管障礙。此外，技術創新的快節奏要求醫療保健提供者不斷適應，這可能會造成採用障礙。

創新應著重於開發具有成本效益的解決方案，並增強無線連接和與其他手術系統的互通性。探索非侵入式監控技術可以為業務成長開闢新的途徑。 IONM 市場的本質是動態的，其特點是不斷的技術創新和競爭格局。為了保持競爭力，公司應優先考慮策略夥伴關係、持續的技術更新以及針對醫療保健專業人員的全面培訓計劃。透過積極應對這些挑戰並利用新技術，公司可以加速成長並擴大市場佔有率。

市場動態：快速發展的術中神經監測市場的關鍵市場洞察

供需的動態交互作用正在改變術中神經監測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 與各種生活方式相關的慢性病盛行率增加
    • 優惠的報銷政策和更安全的手術需求
    • 外包和術中神經監測的趨勢不斷增加
  • 市場限制因素
    • 治療費用上漲
  • 市場機會
    • 神經監測技術進步可最大程度地降低手術過程中的風險
    • 政府機構加大研發投入
  • 市場挑戰
    • 缺乏熟練的專業人員和意識低

波特五力：駕馭術中神經監測市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解術中神經監測市場的外部影響

外部宏觀環境因素在塑造術中神經監測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解術中神經監測市場的競爭狀況

對術中神經監測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣術中神經監測市場供應商的績效評估

FPNV 定位矩陣是評估術中神經監測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了術中神經監測市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，術中神經監測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 與不同生活方式相關的慢性病增加
      • 要求優惠的報銷政策和更安全的手術方法
      • 外包術中神經監測的趨勢不斷增加
    • 抑制因素
      • 治療費用高
    • 機會
      • 神經監測技術進步可最大程度地降低手術過程中的風險
      • 政府機構加大研發投入
    • 任務
      • 缺乏熟練的專業人員和意識低
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章術中神經監測市場：依類型

  • 內源IONM
  • 外包 IONM

第7章術中神經監測市場：依方式

  • 腦幹聽覺誘發電位
  • 腦電圖測試
  • 肌電圖
  • 運動誘發電位
  • 體感誘發電位
  • 視覺誘發電位

第8章術中神經監測市場：依應用分類

  • 耳鼻喉科手術
  • 神經外科
  • 整形外科
  • 脊椎手術
  • 血管外科

第9章北美和南美的術中神經監測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區術中神經監測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的術中神經監測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Accurate Monitoring, LLC
  • Argos Neuromonitoring LP
  • Biotronic NeuroNetwork, LLC
  • Cadwell Industries, Inc.
  • Computational Diagnostics, Inc.
  • Emotiv Inc.
  • inomed Medizintechnik GmbH
  • Intranerve, LLC
  • Medsurant Health
  • Medtronic PLC
  • Moberg Research Inc.
  • Natus Medical Incorporated
  • NeuroMonitoring Technologies
  • NeuroSentinel LLC
  • Nihon Kohden Corporation
  • NuVasive Inc
  • Procirca
  • ProPep Surgical
  • SpecialtyCare, Inc.
Product Code: MRR-AD36CD8980BB

The Intraoperative Neuromonitoring Market was valued at USD 3.13 billion in 2023, expected to reach USD 3.31 billion in 2024, and is projected to grow at a CAGR of 5.69%, to USD 4.62 billion by 2030.

Intraoperative neuromonitoring (IONM) is a specialized procedure used during surgeries to monitor the neural pathways in real-time, reducing the risk of nerve or spinal cord damage. The necessity of IONM stems from its ability to provide immediate feedback to surgeons, enhancing patient safety, particularly during complex surgeries involving the brain, spine, and nerves. Its applications are broad, spanning orthopedic, neurosurgical, vascular, and ENT procedures. The end-use scope includes hospitals, surgical centers, and specialty clinics, where demand is driven by the increasing volume of surgeries and the desire to minimize surgical complications.

KEY MARKET STATISTICS
Base Year [2023] USD 3.13 billion
Estimated Year [2024] USD 3.31 billion
Forecast Year [2030] USD 4.62 billion
CAGR (%) 5.69%

Market insights reveal several key factors influencing growth, including technological advancements, an aging population requiring more surgeries, and increasing awareness among healthcare professionals about patient safety benefits. Opportunities abound in emerging markets, where healthcare infrastructure is expanding, and in the integration of artificial intelligence and machine learning to enhance monitoring accuracy and predictive analytics. To seize these opportunities, companies should focus on expanding their presence in these regions and investing in R&D for more sophisticated, user-friendly devices.

Challenges impeding market growth include high equipment costs, a shortage of skilled professionals to operate IONM technologies, and complex regulatory hurdles. Furthermore, the rapid pace of technological change demands constant adaptation by healthcare providers, which can be a barrier for widespread adoption.

Innovation should concentrate on developing cost-effective solutions and enhancing wireless connectivity and interoperability with other surgical systems. Research into non-invasive monitoring techniques could offer new avenues for business growth. The nature of the IONM market is dynamic, characterized by continuous technological innovations and a competitive landscape. Businesses should prioritize strategic partnerships, continuous technological updates, and comprehensive training programs for healthcare professionals to maintain a competitive edge. By being proactive in addressing these challenges and leveraging new technologies, businesses can drive growth and establish a strong market presence.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intraoperative Neuromonitoring Market

The Intraoperative Neuromonitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of various lifestyles associated chronic diseases
    • Favorable reimbursement policies and demand for safer surgery practices
    • Rising trend of outsourcing Intraoperative Neuromonitoring
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Technological advancements in neuromonitoring to minimize the risks during surgery
    • Increased R&D investments by governmental bodies
  • Market Challenges
    • Dearth of skilled professionals and low awareness

Porter's Five Forces: A Strategic Tool for Navigating the Intraoperative Neuromonitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intraoperative Neuromonitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intraoperative Neuromonitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intraoperative Neuromonitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intraoperative Neuromonitoring Market

A detailed market share analysis in the Intraoperative Neuromonitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intraoperative Neuromonitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intraoperative Neuromonitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intraoperative Neuromonitoring Market

A strategic analysis of the Intraoperative Neuromonitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intraoperative Neuromonitoring Market, highlighting leading vendors and their innovative profiles. These include Accurate Monitoring, LLC, Argos Neuromonitoring LP, Biotronic NeuroNetwork, LLC, Cadwell Industries, Inc., Computational Diagnostics, Inc., Emotiv Inc., inomed Medizintechnik GmbH, Intranerve, LLC, Medsurant Health, Medtronic PLC, Moberg Research Inc., Natus Medical Incorporated, NeuroMonitoring Technologies, NeuroSentinel LLC, Nihon Kohden Corporation, NuVasive Inc, Procirca, ProPep Surgical, and SpecialtyCare, Inc..

Market Segmentation & Coverage

This research report categorizes the Intraoperative Neuromonitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Insource IONM and Outsource IONM.
  • Based on Modality, market is studied across Brainstem Auditory Evoked Potentials, Electroencephalography, Electromyography, Motor Evoked Potentials, Somatosensory Evoked Potentials, and Visual Evoked Potentials.
  • Based on Application, market is studied across ENT Surgery, Neurosurgery, Orthopedic Surgery, Spinal Surgery, and Vascular Surgery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of various lifestyles associated chronic diseases
      • 5.1.1.2. Favorable reimbursement policies and demand for safer surgery practices
      • 5.1.1.3. Rising trend of outsourcing Intraoperative Neuromonitoring
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in neuromonitoring to minimize the risks during surgery
      • 5.1.3.2. Increased R&D investments by governmental bodies
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals and low awareness
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intraoperative Neuromonitoring Market, by Type

  • 6.1. Introduction
  • 6.2. Insource IONM
  • 6.3. Outsource IONM

7. Intraoperative Neuromonitoring Market, by Modality

  • 7.1. Introduction
  • 7.2. Brainstem Auditory Evoked Potentials
  • 7.3. Electroencephalography
  • 7.4. Electromyography
  • 7.5. Motor Evoked Potentials
  • 7.6. Somatosensory Evoked Potentials
  • 7.7. Visual Evoked Potentials

8. Intraoperative Neuromonitoring Market, by Application

  • 8.1. Introduction
  • 8.2. ENT Surgery
  • 8.3. Neurosurgery
  • 8.4. Orthopedic Surgery
  • 8.5. Spinal Surgery
  • 8.6. Vascular Surgery

9. Americas Intraoperative Neuromonitoring Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intraoperative Neuromonitoring Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intraoperative Neuromonitoring Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accurate Monitoring, LLC
  • 2. Argos Neuromonitoring LP
  • 3. Biotronic NeuroNetwork, LLC
  • 4. Cadwell Industries, Inc.
  • 5. Computational Diagnostics, Inc.
  • 6. Emotiv Inc.
  • 7. inomed Medizintechnik GmbH
  • 8. Intranerve, LLC
  • 9. Medsurant Health
  • 10. Medtronic PLC
  • 11. Moberg Research Inc.
  • 12. Natus Medical Incorporated
  • 13. NeuroMonitoring Technologies
  • 14. NeuroSentinel LLC
  • 15. Nihon Kohden Corporation
  • 16. NuVasive Inc
  • 17. Procirca
  • 18. ProPep Surgical
  • 19. SpecialtyCare, Inc.

LIST OF FIGURES

  • FIGURE 1. INTRAOPERATIVE NEUROMONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTRAOPERATIVE NEUROMONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTRAOPERATIVE NEUROMONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAOPERATIVE NEUROMONITORING MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY INSOURCE IONM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY OUTSOURCE IONM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY BRAINSTEM AUDITORY EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ELECTROMYOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MOTOR EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY SOMATOSENSORY EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY VISUAL EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ENT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. INTRAOPERATIVE NEUROMONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. INTRAOPERATIVE NEUROMONITORING MARKET, FPNV POSITIONING MATRIX, 2023